Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/38423
Title: SEOM clinical guidelines for endometrial cancer (2017).
Authors: 
Keywords: 
Mesh: 
Issue Date: Jan-2018
Citation: Clin Transl Oncol.2018 Jan;(20)1:29-37
Abstract: Endometrial cancer (EC) is the most common gynecological cancer in developed countries. Most patients are diagnosed at an early stage with a low risk of relapse. However, there is a group of patients with a high risk of relapse and poor prognosis. Despite the recent publication of randomized trials, the adjuvant treatment of high-risk EC is still to be defined and there are many open questions about the best approach and the right timing. Unfortunately, the survival of metastatic or recurrent EC is short, due to the poor results of chemotherapy and the lack of a second line of treatment. Advances in the knowledge of the molecular abnormalities in EC have permitted the development of promising targeted therapies.
PMID: 29238915
URI: https://hdl.handle.net/20.500.12530/38423
Rights: openAccess
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. U. La Paz > Artículos
Hospitales > H. U. Infanta Sofía > Artículos
Hospitales > H. U. La Paz > Artículos

Files in This Item:
File Description SizeFormat 
PMC5785608.pdf764.35 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.